How to Buy Tenet Healthcare Stock
Tenet Healthcare Corp
Tenet Healthcare is a medical care facility company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker THC on the NYSE exchange.
Tenet Healthcare stock last closed at $233.20, up 17.17% from the previous day, and has increased 57.16% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.67 percentage points. Tenet Healthcare stock is currently +54.44% from its 52-week low of $151.00, and -5.67% from its 52-week high of $247.21.
As of Jul 24, 2026, there are 86.14M THC shares outstanding. The market capitalization of THC is $20.09B. In the past 24 hours, 4.32M THC shares were traded.
How to Buy Tenet Healthcare Stock
Not sure how to invest in Tenet Healthcare stock? Here's how.
- Decide where to buy Tenet Healthcare stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Tenet Healthcare stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your method of payment and add your information.
- Research Tenet Healthcare stock: The Tenet Healthcare ticker symbol is THC. Is Tenet Healthcare stock a good investment? Should you buy shares of THC? How do THC's underlying business fundamentals look? Do top analysts think Tenet Healthcare is a good buy? Why has THC's stock price moved recently? (Hint: Our stock analysis website can help you decide if THC is a good stock to buy).
- Place your THC purchase: Decide if you will purchase THC shares at the current market price or use a limit order to purchase THC stock at a given price.
- Monitor your THC investment: Create a watchlist to keep tabs on your investment in Tenet Healthcare shares.
Step 1: Decide where to buy Tenet Healthcare stock
You will need an online brokerage account to access the NYSE market and buy THC stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal details so you can invest in THC stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have filled out your info on the stocks app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new investment account.
Step 4: Research Tenet Healthcare stock
After you have figured out the best place to buy Tenet Healthcare stock, it's critical to evaluate their stock before you invest, so you truly understand the risk as well as the opportunity.
Tenet Healthcare quick stats
THC Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on THC's stock page.
Is THC stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge THC's true value.
Using relative valuations measures:
- THC may be undervalued based on its P/E ratio of 12.03x, relative to Medical Care Facilities industry P/E ratio of 16.9x
- THC may be undervalued based on its P/B ratio of 4.17x, relative to Medical Care Facilities industry P/B ratio of 5.39x
You can do additional valuation analysis on THC's stock here.
THC Financials at a glance
Signs that THC is financially healthy:
- Total THC debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the THC balance sheet.
- THC's operating cash flow of $4.37B allows it to safely service it's debt of $13.21B.
- THC profit margin has gone up from 7.1% to 7.8% in the past year.
Signs that THC is not financially healthy:
- There are more long-term liabilities than short-term assets on the THC balance sheet.
- THC earnings of $3.04B is not sufficient to cover its interest payments.
- THC has a relatively high debt to equity ratio of 4.64.
Is it a good time to buy THC stock, according to analysts?
Out of 12 Equities analysts who give recommendations on THC, the consensus analyst rating on THC is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent THC Analyst Upgrades/Downgrades
Ben Hendrix, a top 9% analyst from RBC Capital maintains THC with a buy rating and lowers their THC price target from $277.00 to $236.00, on May 1, 2026.
Matthew Gillmor, a top 11% analyst from KeyBanc maintains THC with a strong buy rating and lowers their THC price target from $250.00 to $225.00, on May 1, 2026.
Ann Hynes, a top 6% analyst from Mizuho maintains THC with a buy rating and raises their THC price target from $235.00 to $265.00, on Mar 12, 2026.
Whit Mayo, a top 22% analyst from Leerink Partners maintains THC with a buy rating and raises their THC price target from $255.00 to $264.00, on Feb 20, 2026.
David S Macdonald, a top 7% analyst from Truist Securities maintains THC with a strong buy rating and raises their THC price target from $240.00 to $270.00, on Feb 17, 2026.
Truist Securities's David S Macdonald raised their price target on Tenet Healthcare (NYSE: THC) by 12.5% from $240 to $270 on 2026/02/17. The analyst maintained their Strong Buy rating on the stock.
Tenet Healthcare reported its Q4 and FY 2025 earnings.
Macdonald said that analysis of the quarter's results and management's FY 2026 accounted for their model adjustments and price target hike.
Earnings Report
Tenet Healthcare reported:
For Q4 2025:
- EPS of $4.70, which beat the Zacks Consensus Estimate by 15.2% and Q4 2024's $3.44.
- Revenue of $5.53B, which beat the Zacks Consensus Estimate by 1.4% and was up 8.9% Y/Y.
For FY 2025:
- EPS of $16.78, up from FY 2024's $11.88.
- Revenue of $21.3B, up from FY 2024's $20.7B.
For FY 2026, management guided:
- EPS of $16.19 to $18.47.
- Revenue of $21.5B to $22.3B.
Chairman & CEO Saum Sutaria, M.D., commented: "2025 extended Tenet's track record of strong revenue growth, disciplined operations, improved margins, and robust free cash flow generation.
"We see continued demand for acute care and ambulatory surgical services in our markets and are confident in our ability to execute on our strategy, deliver quality results for our patients and physician partners, and achieve our full year 2026 expectations."
You can dig deeper into what analysts are projecting on the Tenet Healthcare stock forecast page.
THC Momentum
THC Performance Metrics
Last year, THC earnings were $1.70B. In the past five year, THC's earnings have increased by 38.3% per year. This was slower than the Medical Care Facilities industry average of 51.3%.
Last year, THC revenue was $21.87B. Over the last 5 year, THC's revenue has grown by 3.05% per year. This was slower than the Medical Care Facilities industry average of 8.65%.
You can research THC's earnings and revenue performance here.
Latest Insiders Trades at THC
In the past 12 months, executives and large shareholders at THC have sold more shares than they have bought.
J. Robert Kerrey, Director of THC, was the latest THC insider to sell. They sold $340,873.28 worth of THC stock on May 28, 2026.
Research more about who owns THC stock here.
Can I get consistent income from THC stock?
No, Tenet Healthcare doesn't provide an income stream by paying out dividends.
What do other investors have to say about THC?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your THC purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, place a limit order.
Press the Open button and your broker will place the order.
If you want more help buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your THC investment
Now that you own some shares in THC, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your THC stock.
THC Feed
How to Buy Stock in Tenet Healthcare
To summarize, here are the 6 steps to buy Tenet Healthcare stock:
- Decide where to buy Tenet Healthcare stock
- Create a brokerage account
- Fund your investment account
- Research Tenet Healthcare stock
- Place your THC purchase
- Monitor your THC investment
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Tenet Healthcare, create a watchlist today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.